bladder
Showing 26 - 50 of 9,955
Urine-based Molecular Testing vs Cystoscopy for Surveillance of
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- +2 more
- CxBladder Monitor
- Cystoscopy
-
Scottsdale, Arizona
- +2 more
Nov 14, 2023
Bladder Cancer Trial (Field-Cycling Imaging (FCI))
Not yet recruiting
- Bladder Cancer
- Field-Cycling Imaging (FCI)
- (no location specified)
Apr 26, 2023
Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
-
Chengdu, Sichuan, ChinaWest China Hospital
Aug 10, 2023
Microbial Colonization Trial
Not yet recruiting
- Microbial Colonization
- (no location specified)
Oct 16, 2023
Bladder Cancer Trial in Shibin Al Kawm (CT with contrast, MRI pelvis, TURBT)
Recruiting
- Bladder Cancer
- CT with contrast
- +2 more
-
Shibīn Al Kawm, Menofia, EgyptFaculty of Medicine Menofia University
Sep 14, 2023
Bladder Tumor, Magnetic Resonance Imaging Trial in Guangzhou (MRI)
Recruiting
- Bladder Tumor
- Magnetic Resonance Imaging
- MRI
-
Guangzhou, Guang Dong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Sep 4, 2023
Interstitial Cystitis, Painful Bladder Syndrome, Painful Bladder Syndrome (PBS) Trial (Clarix Flo, Placebo)
Not yet recruiting
- Interstitial Cystitis
- Painful Bladder Syndrome (PBS)
- Clarix Flo
- Placebo
- (no location specified)
Oct 23, 2023
Female Patients With Overactive Bladder Syndrome Trial in Banqiao (tolterodine, mirabegron, tolterodine , mirabegron)
Not yet recruiting
- Female Patients With Overactive Bladder Syndrome
- tolterodine
- +2 more
-
Banqiao, New Taipei, TaiwanDepartment of Obstetrics and Gynecology, Far Eastern Memorial Ho
Jul 13, 2023
Lower Urinary Tract Symptoms, Voiding Disorders, Enuresis Trial in Belgium (Minze Diary Pod, Paper bladder diary)
Recruiting
- Lower Urinary Tract Symptoms
- +3 more
- Minze Diary Pod
- Paper bladder diary
-
Edegem, Antwerpen, Belgium
- +4 more
Oct 1, 2023
Neuroendocrine Carcinoma of the Bladder, Bladder Cancer Trial (Adebrelimab, Etoposide, Cisplatin)
Not yet recruiting
- Neuroendocrine Carcinoma of the Bladder
- Bladder Cancer
- Adebrelimab
- +3 more
- (no location specified)
Oct 14, 2023
Cisplatin-Ineligible Metastatic Bladder Cancer and The Role of
Not yet recruiting
- Bladder Cancer
- +3 more
- Geriatric-8 Survey
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 14, 2023
Bladder Cancer Trial (Multi4)
Not yet recruiting
- Bladder Cancer
- Multi4
- (no location specified)
Nov 14, 2023
Overactive Bladder Syndrome Trial in Watertown (V117957, Placebo)
Recruiting
- Overactive Bladder Syndrome
- V117957
- Placebo
-
Watertown, MassachusettsBay State Clinical Trials, Inc.
Aug 29, 2023
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
Recruiting
- Urothelial Carcinoma
- +2 more
-
Recife, Pernambuco, Brazil
- +6 more
Jul 11, 2023
BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder
Recruiting
- Bladder Cancer
-
Little Rock, Arkansas
- +2 more
Aug 6, 2023
Placenta Accreta Spectrum, Cesarean Hysterectomy Trial in Cairo (Late bladder dissection, early bladder dissection)
Recruiting
- Placenta Accreta Spectrum
- Cesarean Hysterectomy
- Late bladder dissection
- early bladder dissection
-
Cairo, EgyptCairo University
Feb 22, 2023
Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- +2 more
- PDD-TURBT with hexaminolevulinate (Hexvix®)
- Power Led Saphira (TM) from KARL STORZ
- (no location specified)
Jul 24, 2023
Overactive Bladder Syndrome Trial in Istanbul (Using mobile app)
Enrolling by invitation
- Overactive Bladder Syndrome
- Using mobile app
-
Istanbul, TurkeyMarmara University
Mar 29, 2023
Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)
Recruiting
- Bladder Cancer
- Pseudomonas aeruginosa
-
Jinan, Shandong, ChinaQilu hospital
Jul 26, 2023
Overactive Bladder Trial in New Taipei City (electroacupuncture, sham acupuncture)
Recruiting
- Overactive Bladder
- electroacupuncture
- sham acupuncture
-
New Taipei City, TaiwanBuddhist Taipei Tzu Chi General Hospital
Aug 9, 2023
Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive
Recruiting
- Non Muscle Invasive Bladder Cancer
- N803 plus Bacillus Calmette-Guerin (BCG)
-
Honolulu, HawaiiIsland Urology
Aug 7, 2023
Overactive Bladder Syndrome, Urinary Incontinence Trial in Redwood City (Patient Engagement Tool)
Not yet recruiting
- Overactive Bladder Syndrome
- Urinary Incontinence
- Patient Engagement Tool
-
Redwood City, CaliforniaStanford Pelvic Health Center
Oct 16, 2023
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle (Best
Not yet recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Best Practice
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 18, 2023
Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics Trial in Seoul (Mirabegron
Active, not recruiting
- Patients With Low Bladder Compliance of 20ml/H2O or Less Despite Taking Anticholinergics
- Mirabegron (beta3-adrenoceptor agonist), Anticholinergics
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Feb 15, 2023
Overactive Bladder, Overactive Bladder Syndrome Trial in Maribor (mirabegron 50 mg daily, Extracorporeal magnetic innervation
Completed
- Overactive Bladder
- Overactive Bladder Syndrome
- mirabegron 50 mg daily
- +2 more
-
Maribor, SloveniaUniversity Medical Centre Maribor
Nov 8, 2023